Fatima Morgana Pio Fonseca

Federal University of São Paulo (UNIFESP)

Rua Sena Madureira, 1500 - 5º andar

Vila Clementino

São Paulo, Sao Paulo 04021001

Brazil

SCHOLARLY PAPERS

1

DOWNLOADS

846

SSRN CITATIONS

1

CROSSREF CITATIONS

0

Scholarly Papers (1)

1.

Nitazoxanide In Vitro Efficacy Against SARS CoV-2 and In Vivo Superiority to Placebo to Treat Moderate COVID-19 – A Phase 2 Randomized Double-Blind Clinical Trial

Number of pages: 30 Posted: 22 Jan 2021
Federal University of São Paulo (UNIFESP), Institute of Infectious Diseases Emilio Ribas, University of São Paulo (USP) - Division of Infectious Diseases, Hospital Municipal Dr. Francisco Moran, SPDM, INCOR and Beneficência Portuguesa, Hospital Vera Cruz, University of São Paulo (USP) - Division of Infectious Diseases, Federal University of São Paulo (UNIFESP), Federal University of São Paulo (UNIFESP), Federal University of São Paulo (UNIFESP), Federal University of São Paulo (UNIFESP), Federal University of São Paulo (UNIFESP), Federal University of São Paulo (UNIFESP), Federal University of São Paulo (UNIFESP), Federal University of São Paulo (UNIFESP), Federal University of São Paulo (UNIFESP), Intituto Federal de Educação - Ciencia e Tecnologia do Rio de Janeiro, Instituto Oswaldo Cruz/FIOCRUZ and University of São Paulo (USP) - Division of Infectious Diseases
Downloads 846 (57,344)

Abstract:

Loading...

COVID-19; Nitazoxanide; randomized controlled clinical trial; lymphocytes cell activation markers, interleukins